Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mk-0524 (1 trial)
niacin (1 trial)
68ga-nodaga-rgd (1 trial)
sargramostim (leukine) (1 trial)
Atherosclerosis (Phase 4)
Carotid Artery Diseases (Phase 2)
Inflammation (Phase 2)
Plaque, Atherosclerotic (Phase 2)
Trials (3 total)
Trial APIs (4 total)